Showing results (631-640 of 3,470) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|March 1, 1990
Clinical pharmacokinetics after repeated intrapleural bupivacaine administrationD Debruyne, M A Moulin, J Tartiere, et al.Clinical Pharmacokinetics|January 8, 2013
New oral anticoagulants: comparative pharmacology with vitamin K antagonistsFrancesco ScaglioneClinical Pharmacokinetics|December 6, 2012
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior informationCyrielle Dumont, France Mentré, Clare Gaynor, et al.Clinical Pharmacokinetics|December 6, 2012
A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodoneAnne E Olesen, Kim Kristensen, Camilla Staahl, et al.Clinical Pharmacokinetics|September 1, 1990
Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal functionR H Vandenbrom, J M Wierda, S AgostonClinical Pharmacokinetics|September 4, 2013
Clinical pharmacokinetic and pharmacodynamic profile of rivaroxabanWolfgang Mueck, Jan Stampfuss, Dagmar Kubitza, et al.Clinical Pharmacokinetics|June 6, 2013
Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamideWilli Cawello, Uwe Fuhr, Ursula Hering, et al.Clinical Pharmacokinetics|July 2, 2013
Pharmacokinetics of afatinib, a selective irreversible ErbB family blocker, in patients with advanced solid tumoursSven Wind, Marion Schmid, Julia Erhardt, et al.Clinical Pharmacokinetics|May 23, 2013
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patientsPetra C van Rijn-Bikker, Oliver Ackaert, Nelleke Snelder, et al.Clinical Pharmacokinetics|May 25, 2013
Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredientsChristian Ude, Manfred Schubert-Zsilavecz, Mario WurglicsPageof 347